# To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease.

> **NCT04944615** · NA · RECRUITING · sponsor: **CCRF Inc., Beijing, China** · enrollment: 1448 (estimated)

## Conditions studied

- Chronic Total Occlusion of Coronary Artery

## Interventions

- **PROCEDURE:** The guidewire successfully passed the CTO lesion

## Key facts

- **NCT ID:** NCT04944615
- **Lead sponsor:** CCRF Inc., Beijing, China
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-21
- **Primary completion:** 2031-10
- **Final completion:** 2031-10
- **Target enrollment:** 1448 (ESTIMATED)
- **Last updated:** 2023-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04944615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04944615, "To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease.". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04944615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*